Top Tech Companies (768)
Don't see your company?
Create a company profile
Wake Research is an integrated network of premier investigational sites working closely with and meeting the needs of the global biopharmaceutical, biotechnology, medical device, pharmaceutical industry, and clinical research organizations. Wake Research has its proprietary patient database of more than 2 million potential clinical trial participants—men and women, children and adults, across all ethnicities—for all kinds of adaptive and other types of trial designs. Conducting studies since 1984, we have a combined subject database of more than 2 million, and we’re still growing. As of today, our board-certified physicians have completed more than 7,000 successful clinical trials. Clinical trials at our site are always completed on time and with accuracy; we consistently exceed sponsor expectations for integrity, subject enrollment, human protection, and expeditious delivery of accurate evaluable data. Our approach is uncompromising – each study conducted at our site is carefully planned and executed according to regulations with superior quality.
Nanospectra Biosciences develops particle-based therapies for the selective and precise thermal destruction of solid tumors.
Frontage Laboratories, Inc. is a CRO that provides integrated, science-driven, product development services throughout the drug discovery and development process to enable pharmaceutical and biotechnology companies to achieve their development goals. Comprehensive services include drug metabolism and pharmacokinetics, analytical testing and formulation development, preclinical and clinical trial material manufacturing, bioanalysis, preclinical safety and toxicology assessment and early phase clinical studies. Frontage has enabled many biotechnology companies and leading pharmaceutical companies of varying sizes to advance a myriad of molecules through development and file regulatory submissions in the United States, China and other countries.
BioNumerik Pharmaceuticals discovers, develops and commercializes drugs for treating cancer.
Pharmaceutical distributors
AROG Pharmaceuticals, Inc. was formed to expedite and streamline the transition of early stage molecules into areas of unmet therapeutic needs. We are committed to scientifically validated drug development in collaboration with like-minded investigators and institutions.
DiaKine Therapeutics is a development stage company commercializing novel immune modulators for the treatment of diabetes.
Better Clinical Trials through Aggregated Data and Correlative Analytics For over a decade, we have been dedicated to providing biotech, pharmaceutical, and medical device enterprises with the most innovative and complete technology solutions. Drug and medical device development has been made easier, faster and less risky thanks to our pioneering means for integrating, normalizing, reconciling and presenting through a single-user interface the aggregated data, analysis, trends and metrics of all (not just some) study-related data sources -- including investigator sites, diagnostics (labs, imaging, EEG, etc.), RTSM, patient diaries, safety, accounting, drug supply chains and any others. Placing at our fingertips real-time answers to virtually any clinical, operational, and financial question regarding your study or program. Prevail Infoworks - 211 North 13th St, Philadelphia, PA 19107-1610 - +1-267-797-2001
PharmaCord connects manufacturers, patients, care teams, physicians, and payors. We help innovative therapies reach the patients they were intended for, and we provide support services that enhance the patient experience on therapy. We are not your typical reimbursement hub; we are a patient services company aligned with your strategic goals. We solve commercial challenges on behalf of life science companies through three integrated service platforms; Patient Support Services, Pharmacy Services and Manufacturer Support. Free from any conflicting ownership or business interests, our goals are the same as our life science clients – to increase access to therapy – and we will go the extra mile and customize our services to achieve this objective. Together, we can redefine patient support services. Contact us! Email: [email protected] Phone: 502-805-3400 Fax: 866-791-8193
Pharmaceutical manufacturers, payers and government organizations have partnered with HealthVerity to solve some of their most complicated use cases through transformative technologies and real-world data infrastructure. The HealthVerity IPGE platform, based on the foundational elements of Identity, Privacy, Governance and Exchange, enables the discovery of RWD across the broadest healthcare data ecosystem, the building of more complete and accurate patient journeys and the ability to power best-in-class analytics and applications with flexibility and ease. Together with our partners, HealthVerity has built the modern way to data for the health insights economy.
.jpeg)
.png)
Vivid Genomics is a developer of noninvasive genomic tools designed to identify top candidates for clinical trials.
OmniSight Interactive provides virtual tours, 3D video animation, virtual marketing and advertising services.
For over 30 years, Particle Dynamics has supplied innovative technologies, quality ingredients and custom processing capabilities that deliver solutions for our customers. Simply said, our technologies make our customers’ products to perform better. We provide particle processing, delivery technologies, and dose manufacturing to the pharmaceutical, consumer health, OTC, and nutraceutical markets. Particle Dynamics is organized around six key Technology and Service lines, including Spray Drying, Continuous Granulation, Microencapsulation, Iron Deficiency Technologies, Dose Manufacturing and Product/Process Innovation Services. In addition, the company holds leading global positions in Direct Compression products such as Direct Compression Calcium Carbonate and Magnesium Carbonate. However ahead of all of the great technologies and products comes our people. Our dedicated employees are the fuel that drives our success, and the Particle Dynamics team is passionate, dedicated, and driven – bringing real value to our customers by providing solutions. Our team takes pride in knowing that the products we deliver are positively impacting the human condition; touching millions of people around the globe by addressing major global health challenges such as iron deficiency, anemia, and prenatal nutrition. For those who would like to join our growing team, Particle Dynamics offers a strong benefits package including generous paid time off, company paid disability, matching 401K plan, medical, dental, and vision coverage, and much more! At Particle Dynamics we work closely to ensure our employees and our customers work in partnership, motivated to achieve great things together, and celebrate our common successes!
Promentis Pharmaceuticals focuses on developing antipsychotic drugs to treat schizophrenia.
Founded in 1991, GM Pharmaceuticals develops and markets prescription and over-the-counter medications and nutritional supplements, including a broad range of health care products for such conditions as cardiovascular and upper-respiratory health, cough, cold, allergy and pain relief. The company, with operations headquartered in Arlington, Texas, maintain a business model manifesting the delivery of quality products, the cultivation of customer relationships in the health care industry and the expertise in product innovation and development. Committed to providing effective medications at a cost-effective and affordable means, GM Pharmaceuticals also is dedicated to providing customers with enlightening and helpful information on some of the most primary areas of health care: prevention, relief and wellness.
FibroGen, Inc., headquartered in San Francisco, with subsidiary offices in Beijing and Shanghai, is a leading biopharmaceutical company committed to discovering, developing, and commercializing a pipeline of first-in-class therapeutics. The Company applies its pioneering expertise in connective tissue growth factor (CTGF) biology and hypoxia-inducible factor (HIF) to advance innovative medicines for the treatment of unmet needs. Pamrevlumab, an anti-CTGF human monoclonal antibody, is in clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), locally advanced unresectable pancreatic cancer (LAPC), and Duchenne muscular dystrophy (DMD). The Company is currently developing and commercializing roxadustat, an oral small molecule inhibitor of HIF prolyl hydroxylase activity for anemia associated with chronic kidney disease (CKD), anemia associated with myelodysplastic syndromes (MDS), and for chemotherapy-induced anemia (CIA). FibroGen recently expanded its research and development portfolio to include product candidates in the immuno-oncology and autoimmune space. For more information, please visit www.fibrogen.com.
Segal Trials, founded in 1998, is a privately held network of seven research sites throughout South Florida conducting Phase I-IV research trials with a primary emphasis on psychiatry, neurology, addiction, insomnia, general medicine, healthy volunteers, infectious diseases, vaccines, and women’s health. Staying true to its core values of quality, customer service, advocacy, and patient care, the Segal Trials team of over 110 professionals remains agile and competitive, expanding and growing based on the needs of its sponsors and its patients. Federal law requires that every medication must go through a series of clinical research trials before being approved by the FDA, in addition to being approved by an independent Research Ethics Board. Clinical research trials are critical in the advancement of medicine and making available new and helpful medications. It is Segal Trials’ mission to play an integral role in the advancement process and help millions of people suffering from diseases.
NeurOp is a research company developing different drug compounds.
Nanobot Medical Animation delivers digital solutions for the pharmaceutical, biotech and medical device industries.
Established in 2005, Bioscript Group is formed from multiple, specialist businesses to support our global pharmaceutical clients; we draw on their multidisciplinary expertise to help navigate critical decisions at key points in the product lifecycle. Our scientific and strategic expertise help our clients make better decisions. We provide medical communication services, market access consulting and regulatory writing support with deep domain expertise to effectively navigate complex disease areas.
